期刊文献+

干扰素治疗慢性乙型肝炎患者B7-H1/PD-1表达与早期病毒学应答的关系 被引量:4

The Relationship between Remedying B7-H1/PD-1 Expression of Chronic Hepatitis B with Pegylated Interferon α-2a and Early Virological Response
原文传递
导出
摘要 目的初步探讨聚乙二醇干扰素α-2a治疗慢性乙型肝炎患者T淋巴细胞和mDCs上共刺激分子B7-H1/PD-1表达与早期病毒学应答的关系。方法纵向观察接受聚乙二醇干扰素α-2a治疗的28例CHB患者其mDCs和T细胞上B7-H1/PD-1的表达变化,分析B7-H1/PD-1表达与聚乙二醇干扰素α-2a治疗效果之间的关系。结果聚乙二醇干扰素α-2a治疗12周时,早期病毒学应答组患者B7-H1在CD3+T细胞、CD4+T细胞、CD8+T细胞、mDC上表达及PD-1在CD3+T细胞、CD4+T细胞、CD8+T细胞上表达水平均明显低于非早期病毒学应答组患者,两组差异显著,P值分别为0.009,0.009,0.009,0.042,0.004,0.017,0.004。结论聚乙二醇干扰素α-2a抗病毒疗效可能与CHB患者mDCs和T细胞上B7-H1/PD-1的表达相关。 Objective To discuss the relationship between remedying T lymphocytes mDCs and costimulatory molecule of B7-H1/PD-1 expression of chronic hepatitis B with pegylated interferon α-2a and early virological response.Methods Observing expression changes of T lymphocytes mDCs and costimulatory molecule of B7-H1/PD-1 of 28 patients with CHB receiving pegylated interferon α-2a treatment.Analyze the relationship between B7-H1/PD-1 expression and pegylated interferon α-2a treatment effect.Results The expression level of B7-H1 in CD3+T cells,CD4+T cells,CD8+T cells,mDC and PD-1 in CD3+T cells,CD4+T cells,CD8+T cells of early virological response patients were significantly lower than non-early virologic response patients.There were significant differences between the two groups.P values were 0.009,0.009,0.009,0.042,0.004,0.017,0.004.Conclusion Antiviral efficacy of pegylated interferon α-2a may be related to the expression of B7-H1/PD-1 in mDCs and T cells of CHB patients.
作者 耿楠 陈新月
出处 《中国病案》 2011年第8期63-65,共3页 Chinese Medical Record
关键词 慢性乙型肝炎 B7-H1 PD-1 共刺激分子 聚乙二醇干扰素Α-2A Chronic hepatitis B B7-H1 PD-1 Costimulatory molecule Pegylated interferon α-2a
  • 相关文献

参考文献5

  • 1Liangen Chen,Zheng Zhang,Weiwei chen,et al.B7-H1 Up-Regulation on Myeloid Dendric Cell Significantly Suppresses T Cell Immune Function In Patients with Chronic Hepatitis B[J].J Immunol,2007,178:6634-6641.
  • 2Trabattoni D,Saresella M,Biasin M,et al.B7-H1 is up-regulated in HIV-infection and is a novel surrogate marker of disease progression[J].Blood,2003,101(7):2514-2520.
  • 3Schwartz RH.A cell culture mode for T lymphocyte clonal anergy[J].Science,1990,4961:1349-1356.
  • 4Kakimi K,Isogawa M,Chung J,et al.Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins:implications for Immunotherapy of persistent viral infections[J].J Virol,2002,76(17):8609-8620.
  • 5慢性乙型肝炎防治指南[J].肝脏,2005,10(4):348-357. 被引量:272

二级参考文献15

共引文献271

同被引文献63

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部